Sort
82,697 grants matching “vaccine development”
Medical Scientist Training Program
$1,574,716Christopher S. Williams · Vanderbilt University · T32 · FY2025 · GM
Functional Biology Of T Cells
$1,574,498Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Neutralizing Botulinum Neurotoxin with Human Antibodies
$1,574,387Rae Lyn Burke · Sri International · U01 · FY2006 · AI
Increasing access to safe and effective products for the prevention, diagnosis and treatment of priority diseases, especially for use in low-and middle-income countries.
$1,574,300Michael Ward · World Health Organization · U01 · FY2016 · FD
Development Of New Approaches To Vaccines Against Neurotropic Flaviviruses
$1,573,911Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Institute of Human Virology Clinical Trials Unit
$1,573,448William Albert Blattner · University Of Maryland Baltimore · U01 · FY2007 · AI
Cellular & Molecular Defects in Human B Cell Development
$1,573,400Charlotte Cunningham-Rundles · Icahn School Of Medicine At Mount Sinai · P01 · FY2009 · AI
Identifying Epitopes Recognized by Influenza and Flavivirus.
$1,572,960William W. Kwok · Benaroya Research Inst At Virginia Mason · N01 · FY2013 · AI
Noroviruses and Epidemic Gastroenteritis
$1,572,836Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Modeling affinity maturation at molecular resolution
$1,572,724Thomas B Kepler · Boston University Medical Campus · U19 · FY2017 · AI
Bacteriophage virus-like particle vaccines for fentanyl and heroin overdose
$1,572,708Bryce C Chackerian · University Of New Mexico Health Scis Ctr · UG3 · FY2021 · DA
Integrated Support Services
$1,572,457Joan Elizabeth Nichols · University Of Texas Med Br Galveston · UC7 · FY2014 · AI
Development of a Chimeric Syphilis Vaccine Candidate to Combat Local, Disseminated and Congenital Syphilis Infection
$1,572,419Caroline E Cameron · University Of Victoria · U01 · FY2025 · AI
MOLECULAR BIOLOGY OF EPSTEIN-BARR VIRUS INFECTION
$1,572,115Brigham And Women'S Hospital · R35 · FY2000 · CA
CANCER CHEMOTHERAPY PROGRAM PROJECT
$1,571,820Sloan-Kettering Institute For Cancer Res · P01 · FY2003 · CA
First-in-human study of two anti-SARS CoV-2 antibodies in health volunteers
$1,571,599Luis J. Montaner · Wistar Institute · UM1 · FY2021 · AI
Structural characterization of OM proteins from Gram-negative pathogens
$1,571,571Susan Buchanan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Evaluation of HIV-1 Vaccine Candidates in Macaca mulatta
$1,571,377Lindsay M. Wohlers · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2008 · AI
BROADLY EFFECTIVE NEUTRALIZATION AND CTL AGAINST HIV 1
$1,571,351Henry M. Jackson Fdn For The Adv Mil/Med · P01 · FY2001 · AI
Preventive Vaccines for HIV
$1,571,294Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Gametocyte Carriage Rate and Transmission Blocking Vaccine Assay Development
$1,571,199Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$1,570,973Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Respiratory Syncytial Virus: Diagnostics Development - VTEU
$1,570,670Kathryn Margaret Edwards · Vanderbilt University · N01 · FY2015 · AI
Host Defense Against HIV-related Pulmonary Infections
$1,570,572Judd E Shellito · Lsu Health Sciences Center · P01 · FY2008 · HL
BROADLY EFFECTIVE NEUTRALIZATION AND CTL AGAINST HIV 1
$1,570,350Henry M. Jackson Fdn For The Adv Mil/Med · P01 · FY2003 · AI